DOXISOME

Welcome to the Brand page for “DOXISOME”, which is offered here for Antibacterial pharmaceuticals; antibacterial substances for medical purposes; antibiotic preparations; antibiotics; antimicrobials for dermatologic use; antiseptic preparations; antiseptics; anti-cancer preparations; bactericides; bacteriostats for medicinal, dental and veterinary use; chemotherapeutics; pharmaceutical preparations for use in chemotherapy; pharmaceutical preparations for the treatment of cancers; pharmaceutical preparations for the prevention of cancers; pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system; for the treatment of inflammatory disorders; for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti- infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancers; reagents for medical use; tumor suppressing agents;.

Its status is currently believed to be active. Its class is unavailable. “DOXISOME” is believed to be currently owned by “Taiwan Liposome Co., Ltd.”